A new study suggests that testing positive for lupus anticoagulant antibodies in the first trimester of pregnancy is the strongest predictor of pregnancy loss in women with lupus.
April 1 is the deadline for late-breaking abstract submissions and for registration by poster presenters at the Federation of Clinical Immunology Societies (FOCiS) Annual Meeting June 24-27 in San Diego.
Additional data from the CDC National Lupus Patient Registry project demonstrates that lupus is a widespread disease with a significant impact.
The Lupus Foundation of America announced today that the Foundation is seeking grant applications to provide critical funding that will, for the first time, address an unmet need in pediatric lupus nephritis.
New Tool Helps to Ensure Better Representation of Minorities in Future Lupus Quality of Life Studies
Researchers now have a cost effective tool to help them better understand the burden of disease among populations at high risk for developing lupus. Learn more.
Researchers from the University of California and Brigham and Women’s Hospital in Boston recently examined adherence among Medicaid beneficiaries with lupus to prescribed medications and found the patients were not following treatment plans, putting themselves at risk for poor outcomes.